58-68-4 (二氢烟酰胺-腺嘌呤二核苷酸,Adenosine 5'-(trihydrogen diphosphate), P'→5'-ester with 1,4-dihydro-1-β-D-ribofuranosyl-3-pyridinecarboxamide)

CAS号:
58-68-4
中文名称:
二氢烟酰胺-腺嘌呤二核苷酸
英文名称:
Adenosine 5'-(trihydrogen diphosphate), P'→5'-ester with 1,4-dihydro-1-β-D-ribofuranosyl-3-pyridinecarboxamide
分子式:
C21H29N7O14P2
分子量:
665.440986394882
植物源:

二氢烟酰胺-腺嘌呤二核苷酸(58-68-4)名称与标识符

名称

中文别名:
二氢烟酰胺-腺嘌呤二核苷酸;
英文别名:
Adenosine5'-(trihydrogen diphosphate), P'®dihydronicotinamide-adenine dinucleotide;Reduced nicotinamide-adenine dinucleotide;5'-ester with 1,4-dihydro-1-b-D-ribofuranosyl-3-pyridinecarboxamide; β- NADH; β-DPNH; Reduced nicotinamide-adenine dinucleotide (NADH); Reduced nicotinamide-adenine dinucleotide; Reduced nicotinamide adenine diphosphate; Reduced diphosphopyridine nucleotide; Reduced codehydrogenase I; Nicotinamide-adenine dinucleotide, reduced; Nicotinamide adenine dinucleotide 2 (reduced form); NADH ; N 8129; ENADA; Dihydronicotinamide mononucleotide; Dihydronicotinamide adenine dinucleotide; Dihydrocozymase; Dihydrocodehydrogenase I; DPNH; Cozymase I, reduced; Coenzyme I, reduced; Codehydrogenase I, reduced; Codehydrase I, reduced; 1,4-Dihydronicotinamide adenine dinucleotide; Adenosine pyrophosphate, 5'→5'-ester with 1,4-dihydro-1-β-D-ribofuranosylnicotinamide (7CI);Adenosine 5'-(trihydrogen pyrophosphate), 5'→5'-ester with 1,4-dihydro-1-β-D-ribofuranosylnicotinamide (8CI);Adenosine 5'-(trihydrogen diphosphate), P'→5'-ester with 1,4-dihydro-1-β-D-ribofuranosyl-3-pyridinecarboxamide;Coenzyme I, reduced;NAD-reduced;dihydrodiphosphopyridine nucleotide;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate;nadh hydride;Codehydrogenase I, reduced;bmse000054;C00004;NADH;Adenosine pyrophosphate, 5'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosylnicotinamide (7CI);CHEBI:16908;Adenosine 5'-(trihydrogen pyrophosphate), 5'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosylnicotinamide (8CI);D0B8SV;Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide, disodium salt;SCHEMBL8187;CHEMBL1234616;nicotinamide adenine dinucleotide (reduced);NADH [WHO-DD];Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide;4J24DQ0916;dihydronicotinamide adenine dinucleotide;Adenosine 5'-(trihydrogen diphosphate), 5'->'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide;DB00157;Dihydrocozymase;Adenosine 5'-(trihydrogen diphosphate), 5'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide, disodium salt;1,4-Dihydronicotinamide adenine dinucleotide;Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide;DPNH;UNII-4J24DQ0916;606-68-8;Adenosine 5'-(trihydrogen diphosphate), P'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide;NADH2;Nicotinaminde-Adenine-Dinucleotide;Q26987453;Reduced Nicotinamide Adenine Dinucleotide;beta-NADH;[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate;diphosphopyridine nucleotide reduced;C21H29N7O14P2;Nicotinamide adenine dinucleotide, reduced form;ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE), P'->5'-ESTER WITH 1,4-DIHYDRO-1-.BETA.-D-RIBOFURANOSYL-3-PYRIDINECARBOXAMIDE;Adenosine 5'-(trihydrogen diphosphate), P'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide (9CI);b-NADH;Dihydronicotinamide mononucleotide;Nicotinamide-adenine dinucleotide, reduced;C21-H29-N7-O14-P2.2Na;C21-H29-N7-O14-P2;[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-[[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-phosphinic acid;EINECS 200-393-0;b-dpnh;coenzyme-I;adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate}; cent-dpnh;Codehydrase I, reduced;Reduced codehydrogenase I;Nicotinamide - adenine dinucleotide, reduced;beta-DPNH;BOPGDPNILDQYTO-NNYOXOHSSA-N;Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with 1,4-dihydro-1beta-D-ribofuranosylnicotinamide;Adenosine 5'-(trihydrogen diphosphate), P'-->5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide;EN300-19742425;[5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [[5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate;58-68-4;NADH+H+;NAD REDUCED FORM [MI];[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinic acid;Dihydrocodehydrogenase I;Cozymase I, reduced;DTXSID30889320;GTPL4487;NAD reduced form;Adenosine 5'-(trihydrogen diphosphate), 5'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide;ENADA;Diphosphopyridine nucleotide,reduced form;Reduced diphosphopyridine nucleotide;C21H29N7O14P2.2Na;Reduced nicotinamide adenine diphosphate;Adenosine 5'-(trihydrogen diphosphate), P'?5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide, disodium salt;adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate};Adenosine pyrophosphate, 5'→5'-ester with 1,4-dihydro-1-β-D-ribofuranosylnicotinamide (7CI);N 8129;Nicotinamide adenine dinucleotide (reduced form);Reduced nicotinamide-adenine dinucleotide (NADH);β-DPNH;β-NADH;((2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy-((((2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl)methoxy)hydroxyphosphoryl)oxyphosphinic acid;NADH dianion;BRD-A84188517-304-01-1;Adenosine 5'-(trihydrogen diphosphate), P'a5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide;HY-113355;CS-0062281;

标识符

MDL:
MFCD00171241
InChIKey:
BOPGDPNILDQYTO-NNYOXOHSSA-N
Inchi:
1S/C21H29N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1,3-4,7-8,10-11,13-16,20-21,29-32H,2,5-6H2,(H2,23,33)(H,34,35)(H,36,37)(H2,22,24,25)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1
SMILES:
P(=O)(O)(OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@H](N2C=CCC(C(N)=O)=C2)O1)O)O)OC[C@@H]1[C@H]([C@H]([C@H](N2C=NC3C(N)=NC=NC2=3)O1)O)O

二氢烟酰胺-腺嘌呤二核苷酸(58-68-4)物化性质

计算特性

  • 精确分子量 : 665.12477262g/mol
  • 氢键供体数量 : 8
  • 氢键受体数量 : 19
  • 可旋转化学键数量 : 11
  • 同位素质量 : 665.12477262g/mol
  • 重原子数量 : 44
  • 复杂度 : 1230
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 8
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : -5.7
  • 拓扑分子极性表面积 : 318Ų

二氢烟酰胺-腺嘌呤二核苷酸(58-68-4)推荐厂家 更多厂家(8)

公司名称手机号/电话联系人QQ微信询单
上海楷森生物科技有限公司 17558870519
175-58870519
赵经理
询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
南通众合化工新材料有限公司 18762756250
0513-55074056
胡经理 2369399482
询单
南通众合化工新材料有限公司 18762756250
0513-55074056
胡经理 2369399482
询单
上海依赫生物科技有限公司 17721395025
021-68882955
张经理 2423903095
询单
杭州六可生物科技有限公司 15658003402
0086-571-86912261
Susan 3671025517
询单
海馨妍(上海)健康科技有限公司 15221765202
021-33282629
刘镒源 1057733794 询单
深圳市美凯特科技有限公司 13421310117
0755-89480936-818
曾先生 2355885870 询单

二氢烟酰胺-腺嘌呤二核苷酸(58-68-4)合成路线

合成路线:1 步
反应条件:
参考文献:
NADH Regeneration: A Case Study of Pt-Catalyzed NAD+ Reduction with H2
By Saba, Tony et al, ACS Catalysis, 2021, 11(1), 283-289
合成路线:1 步
反应条件:
参考文献:
Iridium(2+), triaqua[(1,2,3,4,5-)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl]-, sulfate (1:1)
By Noshi, Mohammad N., e-EROS Encyclopedia of Reagents for Organic Synthesis, 2014, From e-EROS Encyclopedia of Reagents for Organic Synthesis, 1-4
合成路线:1 步
反应条件:
参考文献:
Factors influencing the operational stability of NADPH-dependent alcohol dehydrogenase and an NADH-dependent variant thereof in gas/solid reactors
By Kulishova, Liliya et al, Journal of Molecular Catalysis B: Enzymatic, 2010, 67(3-4), 271-283
合成路线:1 步
反应条件:
参考文献:
The visible-light-driven transfer hydrogenation of nicotinamide cofactors with a robust ruthenium complex photocatalyst
By Dong, Wenjin et al, Green Chemistry, 2020, 22(7), 2279-2287
合成路线:1 步
反应条件:
参考文献:
Solar Light Responsive Graphitic Carbon Nitride Coupled Porphyrin Photocatalyst that Uses for Solar Fine Chemical Production
By Mishra, Shaifali et al, Photochemistry and Photobiology, 2023, 99(4), 1080-1091
合成路线:1 步
反应条件:
参考文献:
Polystyrene-based eosin-Y as a photocatalyst for solar light-mediated NADH/NADPH regeneration and organic transformations
By Singh, Pooja et al, Reaction Chemistry & Engineering, 2023, 8(5), 1072-1082
合成路线:1 步
反应条件:
参考文献:
Enzymatic electrosynthesis of glycine from CO2 and NH3
By Wu, Ranran et al, Angewandte Chemie, 2023, 62(14), e202218387
合成路线:1 步
反应条件:
参考文献:
Modular engineering strategy to redirect electron flux into the electron-transfer chain for enhancing extracellular electron transfer in Shewanella oneidensis
By Ding, Qinran et al, ACS Synthetic Biology, 2023, 12(2), 471-481
合成路线:1 步
反应条件:
参考文献:
Aerobic photobiocatalysis enabled by combining core-shell nanophotoreactors and native enzymes
By Wei, Wenxin et al, Journal of the American Chemical Society, 2022, 144(16), 7320-7326
合成路线:1 步
反应条件:
参考文献:
Non-covalent metalation of carbon nitride for photocatalytic NADH regeneration and enzymatic CO2 reduction
By Zhang, Yuanyuan et al, Chemical Communications (Cambridge, 2022, 58(78), 10997-11000
合成路线:1 步
反应条件:
参考文献:
Visible-light-induced enzymatic reactions using an NADH regeneration system of water-soluble zinc porphyrin and homogeneous colloidal rhodium nanoparticles
By Katagiri, Takayuki and Amao, Yutaka, Sustainable Energy & Fuels, 2022, 6(10), 2581-2592
合成路线:1 步
反应条件:
参考文献:
Visible light driven selective NADH regeneration using a system of water-soluble zinc porphyrin and homogeneous polymer-dispersed rhodium nanoparticles
By Katagiri, Takayuki and Amao, Yutaka, New Journal of Chemistry, 2021, 45(35), 15748-15752
合成路线:1 步
反应条件:
参考文献:
Accelerated green process of 2,5-dimethylpyrazine prodn. from glucose by genetically modified Escherichia coli
By Xu, Jianzhong et al, ACS Synthetic Biology, 2020, 9(9), 2576-2587
合成路线:1 步
反应条件:
参考文献:
Pyrimidoquinxoalinophenanthroline opens next chapter in design of bridging ligands for artificial photosynthesis
By Brueckmann, Jannik et al, ChemRxiv, 2021, From ChemRxiv, 1-19
合成路线:1 步
反应条件:
参考文献:
Chemoselective NADH Regeneration: the Synergy Effect of TiOx and Pt in NAD+ Hydrogenation
By Wang, Maodi et al, ACS Sustainable Chemistry & Engineering, 2021, 9(18), 6499-6506
合成路线:1 步
反应条件:
参考文献:
Can a Nonorganometallic Ruthenium(II) Polypyridylamine Complex Catalyze Hydride Transfer? Mechanistic Insight from Solution Kinetics on the Reduction of Coenzyme NAD+ by Formate
By Chrzanowska, Marta et al, Inorganic Chemistry, 2020, 59(20), 14944-14953
合成路线:1 步
反应条件:
参考文献:
A thiophene-modified doubleshell hollow g-C3N4 nanosphere boosts NADH regeneration via synergistic enhancement of charge excitation and separation
By Meng, Jialin et al, Catalysis Science & Technology, 2019, 9(8), 1911-1921
合成路线:1 步
反应条件:
参考文献:
Construction of fully conjugated covalent organic frameworks via facile linkage conversion for efficient photoenzymatic catalysis
By Wang, Yuancheng et al, Journal of the American Chemical Society, 2020, 142(13), 5958-5963
合成路线:1 步
反应条件:
参考文献:
Fluorescent and Biocompatible Ruthenium-Coordinated Oligo(p-phenylenevinylene) Nanocatalysts for Transfer Hydrogenation in the Mitochondria of Living Cells
By Dai, Nan et al, Chemistry - A European Journal, 2020, 26(20), 4489-4495
合成路线:1 步
反应条件:
参考文献:
Coordination between Electron Transfer and Molecule Diffusion through a Bioinspired Amorphous Titania Nanoshell for Photocatalytic Nicotinamide Cofactor Regeneration
By Yang, Dong et al, ACS Catalysis, 2019, 9(12), 11492-11501
合成路线:1 步
反应条件:
参考文献:
Assessing the environmental performance of NADH regeneration methods: A cleaner process using recyclable Pt/Fe3O4 and hydrogen
By Saba, Tony et al, Catalysis Today, 2020, 339, 281-288
合成路线:1 步
反应条件:
参考文献:
N,O-Chelating quinoline-based half-sandwich organorhodium and -iridium complexes: synthesis, antiplasmodial activity and preliminary evaluation as transfer hydrogenation catalysts for the reduction of NAD+
By Stringer, Tameryn et al, Dalton Transactions, 2019, 48(35), 13143-13148
合成路线:1 步
反应条件:
参考文献:
Emissive Synthetic Cofactors: A Highly Responsive NAD+ Analogue Reveals Biomolecular Recognition Features
By Feldmann, Jonas et al, Chemistry - A European Journal, 2019, 25(17), 4379-4389
合成路线:1 步
反应条件:
参考文献:
Fully conjugated two-dimensional sp2-carbon covalent organic frameworks as artificial photosystem I with high efficiency
By Zhao, Yingjie et al, Angewandte Chemie, 2019, 58(16), 5376-5381
合成路线:1 步
反应条件:
参考文献:
Biocatalytic C=C Bond Reduction through Carbon Nanodot-Sensitized Regeneration of NADH Analogues
By Kim, Jinhyun et al, Angewandte Chemie, 2018, 57(42), 13825-13828
合成路线:1 步
反应条件:
参考文献:
Porphyrin/SiO2/Cp*Rh(bpy)Cl Hybrid Nanoparticles Mimicking Chloroplast with Enhanced Electronic Energy Transfer for Biocatalyzed Artificial Photosynthesis
By Ji, Xiaoyuan et al, Advanced Functional Materials, 2018, 28(9), n/a
合成路线:1 步
反应条件:
参考文献:
Factors influencing the operational stability of NADPH-dependent alcohol dehydrogenase and an NADH-dependent variant thereof in gas/solid reactors
By Kulishova, Liliya et al, Journal of Molecular Catalysis B: Enzymatic, 2010, 67(3-4), 271-283